an article from Meyer et al. (2020) has a good summary of the potential mechanisms through which the presence of COVID-19 could affect clinical trial results.
What should a researcher do when a clinical trial is affected by COVID-19? Here are some analysis considerations.
![](https://www.healthcare-economist.com/wp-content/uploads/2024/02/COVID-3-1024x358.png)
He complete article It’s interesting everywhere.